Evidence map›Paper›PMID 40286155›Full record

ArticleMolecules (Basel, Switzerland)2025

Synthesis and Characterization of Multilayer 3D Chiral Polymers with Enhanced Optical Properties.

Sai Zhang, Xiaobei Jin, Daixiang Chen, Qingzheng Xu, Tao Wang, Xiuyuan Qin, Jialing Mao, Yue Zhang, Shenghu Yan, Guigen Li

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sai ZhangSchool of Pharmacy, Changzhou University, Changzhou 213164, China.ORCID 0009-0004-0826-9650
Xiaobei JinChangzhou Tronly Advanced Electronic Materials Co., Ltd., Changzhou 213011, China.
Daixiang ChenSchool of Pharmacy, Changzhou University, Changzhou 213164, China.
Qingzheng XuSchool of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China.
Tao WangSchool of Pharmacy, Changzhou University, Changzhou 213164, China.
Xiuyuan QinSchool of Life and Science, Nanjing Normal University, Nanjing 210046, China.
Jialing MaoSchool of Environmental Science and Engineering, Changzhou University, Changzhou 213164, China.
Yue ZhangSchool of Environmental Science and Engineering, Changzhou University, Changzhou 213164, China.
Shenghu YanSchool of Pharmacy, Changzhou University, Changzhou 213164, China.
Guigen LiDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409-1061, USA.

Funding

National Key Research Plan of China 2022YFC2105202
6 · The paper itself

Abstract

This study reports the synthesis of novel multilayer 3D chiral polymers using 2,2'-(2,7-Naphthalenediyl)bis[4,4,5,5-tetramethyl-1,3,2-dioxaborolane] and 1,8-dibronaphthalene along with its derivatives as key precursors. Comprehensive characterization was performed using nuclear magnetic resonance (NMR), gel permeation chromatography (GPC), photoluminescence, ultraviolet (UV) spectroscopy, scanning electron microscopy (SEM), polarimetry, dynamic light scattering (DLS), and thermogravimetric analysis (TGA). Notably, the polymers exhibited remarkable aggregation-induced emission (AIE) and aggregation-induced polarization (AIP) phenomena, revealing enhanced luminescence and optical activity in aggregated states. These findings underscore the potential of these chiral polymers for applications in optoelectronics and advanced sensing technologies, highlighting the intricate relationship between molecular structure and optical behavior.

Indexed as

aggregation-induced emissionmultilayer 3D chiral polymer

Identifiers

PMID40286155
PMCPMC11990258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.